CDC expands COVID-19 booster recommendations for Pfizer and Moderna vaccines: The U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for the Pfizer and Moderna COVID-19 Vaccines, shortening the time to five months between completion of a primary series of vaccine and a booster dose and allowing for immunocompromised children, ages 5-18, to receive a third primary series dose.
The CDC recommends:
- Children ages 5-11 who are moderately to severely immunocompromised receive an additional primary dose of Pfizer vaccine.
- Children ages 12-17 should receive a booster shot of the Pfizer vaccine five months after receiving their primary series of the Pfizer vaccine.
- Adults ages 18 and older are eligible for a booster five months after completing a primary series of the Pfizer or Moderna vaccine.
- Adults ages 18 and older are eligible for a booster two months after completing a primary series of the Jansen (J&J) vaccine.
Visit www.fda.gov/covid19vaccines for additional vaccine information.